retatrutide type 2 diabetes trial results 2024 ESC 2024: improves lipid and cardiovascular risk profile in Phase II This data from Phase 3

Can you switch from Semaglutide GLP-1 to Ozempic or vice versa

Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study

Its always important to set realistic expectations, as results are not guaranteed

This simplified the trial design but raises legitimate questions about whether weight-based dosing might improve outcomes

How This Works DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) was first characterized in 1977 as a sleep-modulating factor isolated from rabbit brain [1]

Since then, other GLP-1R agonists such as exenatide (Byetta ) and dulaglutide (Trulicity ) have been approve (Holman et al., 2017